Sagimet Biosciences Inc. SEC filings SGMT

Sagimet Biosciences Inc. has 262 filings in SEC EDGAR's recent list, going back to May 8, 2007. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Sagimet Biosciences Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2026 —
4 Insider transaction Aug 17, 2026 Aug 14, 2026
144 Notice of proposed sale Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 11, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2026 —
4 Insider transaction Jul 22, 2026 Jul 20, 2026
4 Insider transaction Jul 22, 2026 Jul 20, 2026
4 Insider transaction Jul 22, 2026 Jul 20, 2026
144 Notice of proposed sale Jul 20, 2026 —
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction May 14, 2026 Apr 20, 2026
3 Initial insider ownership May 14, 2026 Apr 20, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 18, 2025 —
4 Insider transaction Nov 21, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 6, 2025 Nov 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jul 23, 2025 Jul 21, 2025
4 Insider transaction Jul 23, 2025 Jul 21, 2025
4 Insider transaction Jul 23, 2025 Jul 21, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 24, 2025 —
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
SCHEDULE 13G Ownership over 5% (passive) May 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 7, 2025 Feb 6, 2025
4 Insider transaction Feb 7, 2025 Feb 6, 2025
4 Insider transaction Feb 7, 2025 Feb 6, 2025
4 Insider transaction Feb 7, 2025 Feb 6, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
3 Initial insider ownership Aug 5, 2024 Aug 1, 2024
3 Initial insider ownership Aug 5, 2024 Aug 1, 2024
4 Insider transaction Jul 25, 2024 Jul 23, 2024
144 Notice of proposed sale Jul 23, 2024 —
4 Insider transaction Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jul 23, 2024 Jul 19, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction May 8, 2024 May 6, 2024
3 Initial insider ownership May 8, 2024 May 6, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
3 Initial insider ownership Apr 3, 2024 Apr 1, 2024
3 Initial insider ownership Apr 3, 2024 Apr 1, 2024
4 Insider transaction Mar 28, 2024 Mar 26, 2024
SC 13G/A Amended ownership over 5% (passive) Mar 11, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 5, 2024 —
3 Initial insider ownership Feb 2, 2024 Feb 1, 2024
4 Insider transaction Jan 31, 2024 Jan 29, 2024
4 Insider transaction Jan 31, 2024 Jan 29, 2024
4 Insider transaction Jan 31, 2024 Jan 29, 2024
4 Insider transaction Jan 31, 2024 Jan 29, 2024
4 Insider transaction Jan 31, 2024 Jan 29, 2024
4 Insider transaction Dec 8, 2023 Dec 7, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 20, 2023 Nov 16, 2023
SC 13G Ownership over 5% (passive) Sep 11, 2023 —
4 Insider transaction Sep 8, 2023 Sep 7, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023
3 Initial insider ownership Jul 13, 2023 Jul 13, 2023

Showing 129 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SGMT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Foster City, CA
SEC filer status
, Emerging growth company
SEC CIK
1400118
Former names
3-V Biosciences, Inc. (until Feb 25, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.